FOERFARANDE FOER FRAMSTAELLNING AV GIFTLOESA CYTOSTATBEREDNINGAR

The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic a...

Full description

Saved in:
Bibliographic Details
Main Authors STEKAR JURIJ, BROCK NORBERT
Format Patent
LanguageFinnish
Published 18.08.1979
Edition2
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic acid) having the general formula to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the dithiodi-(alkane sulfonic acid), simultaneously or separately in combination with the alkylating agent.
Bibliography:Application Number: FI19790000426